Key Trends and Insights into the Pharma ADMET Testing Market: Growth Rate and Opportunities to 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What fueled the previous growth in the pharma admet testing market?
In recent years, there has been rapid expansion in the size of the pharma ADMET testing market. The market is projected to grow from $9.67 billion in 2024 to $10.73 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.9%. The historical growth rate can be linked to the development of biopharmaceuticals and biosimilars, an increase in drug development activities, heightened awareness of drug safety, a worldwide diffusion of clinical trials, and a shift towards in silico modeling.
What will be the pharma admet testing market size in the future?
The projected market size for pharma ADMET testing is set to experience considerable rise in the coming years, expanding to a worth of $17.1 billion by 2029 with a compound annual growth rate (CAGR) of 12.4%. This progression in the predicted period is likely due to factors such as environmental toxicology, safety evaluation, the growing attention towards pharmacogenomics, emphasis on precision medicine, along with the expansion of biologics and biosimilars. It also involves the integration of artificial intelligence (AI), enhanced regulatory needs, and a surge in the development of orphan drugs. The forecast timeframe is also expected to see key trends like increased joint ventures in research, swift technological leaps, progression in analytical technologies, ongoing monitoring of drug safety, as well as considerations about environmental impact.
Get your pharma admet testing market report here!
https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report
What main drivers are fueling expansion in the pharma admet testing market?
The escalation in the frequency of product authorizations serves as a propelling factor for the pharma ADMET testing market. These authorizations refer to the procedure in which regulatory bodies like the Food and Drug Administration (FDA) in the United States, or the European Medicines Agency (EMA) in Europe, provide the green light for a product to be sold and advertised to the public. ADMET testing enables the determination of the safety and effectiveness of new products and is compulsory in the regulatory approval of products. For instance, in January 2024, per the National Library of Medicine, a US-based biomedical library and a national resource center, it was stated that 55 new drugs were sanctioned by the U.S. Food and Drug Administration (FDA) in 2023, which is an increase from 37 drugs that were sanctioned in 2022. Hence, the acceleration in product authorizations impels the pharma ADMET testing market.
What key areas define the segmentation of the global pharma admet testing market?
The pharma ADMET testing market covered in this report is segmented –
1) By Testing Type: In Vivo ADMET Testing, In Vitro ADMET Testing, In Silico ADMET Testing
2) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology
3) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications
Subsegments:
1) By In Vivo ADMET Testing: Animal Studies, Pharmacokinetics Studies, Toxicology Studies, Biodistribution Studies
2) By In Vitro ADMET Testing: Metabolism Studies, Drug-Drug Interaction Studies, Absorption Studies, Cytotoxicity and Safety Testing
3) By In Silico ADMET Testing: Predictive Modeling and Simulation, Quantitative Structure-Activity Relationship (QSAR) Analysis, Machine Learning Algorithms for ADMET Predictions, Software Tools for ADMET Profiling
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12024&type=smp
Who are the dominant players expanding their reach in the pharma admet testing market?
Major companies operating in the pharma ADMET testing market include Thermo Fisher Scientific Inc., The Merck Group, Laboratory Corporation of America Holdings, IQVIA Inc., PPD ICON plc, Agilent Technologies Inc., Wuxi AppTec Co. Ltd., Catalent Inc., Covance Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Beckman Coulter Inc., Perkinelmer Inc., Albany Molecular Research Inc., Evotec A.G., CMIC Holdings Co. Ltd., Promega Corporation, Aptuit LLC, Symeres B.V., Biovia Corp., BioIVT LLC, Cyprotex Limited, InSphero AG, Admescope Ltd., Accelrys Inc.
How are evolving market trends shaping pharma admet testing Strategies?
In the pharmaceutical ADMET testing market, product innovation is becoming a prominent trend. Major players in this market are releasing cutting-edge products like Logica to maintain their market dominance. For example, Charles River Laboratories International Inc., an American pharmaceutical company, and Valo Health Inc., an American AI-health solution firm, unveiled Logica, an AI-infused drug development tool, in April 2022. This innovative solution employs Valo’s AI-powered Opal Computational Platform to offer ADMET testing services and other drug delivery solutions. Logica takes advantage of top-tier predictive models, chemical design and synthesis capabilities, DNA coded libraries, and in silico high throughput screening from Valo’s Opal Computational Platform. This is on top of Charles River’s superior capabilities in all areas of discovery optimization including high throughput screening, medicinal chemistry, ADME, biology, pharmacology, with an ultimate goal of safety testing and IND submission.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12024
Which regions are emerging as leaders in the pharma admet testing market?
Asia-Pacific was the largest region in the pharma ADMET testing market in 2024. The regions covered in the pharma ADMET testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Services Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/services-global-market-report
Testing, Inspection, And Certification Global Market Report 2024
Analytical Laboratory Instrument Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
